SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys post-earnings selloff is the main focus, as traders weigh shortfalls in GMV and subscription-related metrics against earnings and cash-flow strength and continued revenue growth. The sharp drop and rebound have split the community between dip buyers calling it an overreaction and bears citing high valuation and moderating growth.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A record fiscal-quarter earnings beat and raised full-year outlook, supported by strong bookings and AI-chip testing demand, drove AEHRs sharp rally. Traders welcomed the results and AI growth prospects, while others questioned the valuation and whether the rebound can hold.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

MDGL is under pressure despite strong Q3 results and its first profitable quarter, with traders focused on the stocks sharp fade after an initial post-earnings jump. Bulls cite Rezdiffras commercial momentum and room to grow, while skeptics point to slow market penetration, reimbursement hurdles, spending, and the wait for clinical-outcomes data.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transoceans quarterly results and newly released fleet status report are driving discussion, with traders debating the reported GAAP versus adjusted earnings and questioning the sharp share-price decline. Some see longer-term support from contracts and the Valaris merger, while others remain concerned about dilution, debt and weak price action.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs strong quarterly results and raised outlook were met with a selloff, as traders focused on slower contract bookings and the stocks high valuation as potential signs that growth may be harder to sustain. Bulls view the pullback as an overreaction to robust AI demand and commercial momentum, while bears argue the bookings trend leaves future growth uncertain.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins third-quarter results and a new share repurchase program are driving attention, with traders highlighting stronger profitability and customer growth. The reaction is divided: bulls see improving fundamentals and buybacks as supportive, while skeptics focus on weak same-store sales, stagnant OTC trading, and uncertainty over a U.S. relisting.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs quarterly results beat expectations, management reaffirmed its outlook, doubled its cost-savings target and announced plans to resume share repurchases, prompting a sharp rebound after a prolonged selloff. Bulls see a potential turnaround, while skeptics remain focused on execution and margin pressures; short-squeeze talk is speculative.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblazes stronger-than-expected Q3 results and raised full-year outlook are driving attention, with traders focused on accelerating B2 cloud-storage growth and its potential role in AI infrastructure. The upbeat reaction has been volatile: bulls see evidence the growth story is gaining traction, while skeptics point to slowing retention, declining legacy backup revenue, and post-earnings profit-taking.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Rokus strong Q3 results, with growth in platform and advertising revenue, are drawing attention as shares reach a 52-week high. Traders are weighing the earnings momentum against the pending Fox acquisition, which caps perceived upside and faces added regulatory scrutiny; Roku also withheld its outlook because of the deal.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the following business segments: Cannabis and Plant Propagation. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Organigrams agreement to acquire Aurora has triggered a sharp rally, overtaking Curaleafs earlier bid. Traders are celebrating the deal while debating whether Curaleaf could counterbid and whether the agreed terms limit further upside for Aurora shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Transforming Data Into Actionable Insights in the Lab

Transforming Data Into Actionable Insights in the Lab Transforming Data Into Actionable Insights in the LabPR NewswireSAN DIEGO, Oct. 29, 2026 SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 62...

QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026

QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026 QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026PR NewswireSAN DIEGO, Oct. 20, 2026SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading...

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR NewswireSAN DIEGO, Oct. 15, 2026 SAN DIEGO, Oct. 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading...

Reasons to Add QuidelOrtho Stock to Your Portfolio for Now

QDEL's strong Q2 results, diversified product portfolio and cost-saving initiatives bolster its growth prospects despite persistent weakness in respiratory demand.

QuidelOrtho Reaches Analyst Target Price

In recent trading, shares of QuidelOrtho Corp (Symbol: QDEL) have crossed above the average analyst 12-month target price of $13.50, changing hands for $14.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val...

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 8, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsPR NewswireSAN DIEGO, Oct. 7, 2026SAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading global...

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis TreatmentPR NewswireSAN DIEGO, Sept. 24, 2026 SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation...

Faster Answers, Better Decisions: ADLM 2026 Highlights

Faster Answers, Better Decisions: ADLM 2026 Highlights Faster Answers, Better Decisions: ADLM 2026 Highlights PR Newswire SAN DIEGO, Aug. 27, 2026 SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode...

Here's What Is Shaping Abbott's Diagnostics Growth

ABT's Diagnostics growth is being reshaped as weaker respiratory testing offsets healthy routine demand and 13% cancer diagnostics growth.

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

QuidelOrtho Corporation

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Advent International, SK Capital Partners and Archimed have expressed interest in the business, the report stated.&nbsp;</li><li>The potential divestiture is aimed at helping QuidelOrtho address its around $2.6-billion net debt load.</li><li>QuidelOrtho’s rapid antigen tests were the first of their kind to be approved by the U.S. Food and Drug Administration during the Covid pandemic.</li></ul>&nbsp;Shares of QuidelOrtho Corporation (QDEL) rocketed 35% on Monday after reports that the diagnostics company is exploring the sale of its point-of-care testing business at a valuation of around $1.5 billion.The stock is now on track for its best day since May 2025, if gains hold.<h2 class="st-heading-2">QDEL Explores Sale For Point-Of-Care Testing Business</h2>QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/404f832c-89cf-49f7-a546-b0e4eb965f15?syn-25a6b1a6=1">reported</a> over the weekend. Private equity firms have already expressed interest in the asset, people familiar with the matter told FT.The potential divestiture is aimed at helping QuidelOrtho address its around $2.6-billion net debt load, which largely stems from the combination of Quidel Corporation and Ortho Clinical Diagnostics in 2022.Advent International, SK Capital Partners and Archimed have expressed interest in the business, the report noted.QuidelOrtho, headquartered in San Diego, is a major player in in vitro diagnostics (IVD), offering a range of laboratory and point-of-care testing solutions. The point-of-care segment includes rapid diagnostic tests used in physician offices, clinics, and other near-patient settings. The company’s rapid antigen tests were the first of their kind to be approved by the US Food and Drug Administration during the Covid pandemic.<h2 class="st-heading-2">How Did QDEL Retail Traders React?</h2>On Stocktwits, retail sentiment around QDEL stock jumped from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume stayed at ‘high’ levels.A Stocktwits user cheered the rally. “getting some life back!!!!,” they wrote.<stembedurl>https://www.stocktwits.com/SETesla77/message/657768907</stembedurl>Another user sees the stock trading around $75, if the company successfully sells its point-of-care business, representing significant upside from current trading levels.<stembedurl>https://www.stocktwits.com/Staska/message/657686493</stembedurl>According to data from Koyfin, one of the five analysts covering QDEL rates it ‘Buy’ while three rate it ‘Hold’ and one rates it a ‘Strong Sell.’ The 12-month average price target on the stock is $18.63, representing a potential upside of about 35% from Friday’s close.&nbsp;<a href="https://stocktwits.com/symbol/QDEL">QDEL stock</a> has lost about 35% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/axon-stock-set-for-best-month-in-over-a-year-what-s-the-trump-connection/cZ1904qR7Lg">AXON Stock Set For Best Month In Over A Year – What’s The Trump Connection?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the QuidelOrtho Corporation (Quidel Ortho) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times reported over the weekend. 

Current Price	$13.89
Prev Close	$14.03
Open	$14.04
Dividend Yield	0.00%
50-Day Moving Average	$12.74
Beta	1.59
Avg. Volume	2.31M
PE Ratio	-0.91

52-Week High	$35.58
52-Week Low	$9.92
Market Capitalization	$962.11M
EPS (Annual)	-$16.69
Price to Book	0.54
Revenue Per Employee	$419,538.46

Feed

News

Sentiment

Earnings

Fundamentals

Info

QDEL Fundamentals